Uzedy (risperidone XR SC suspension) / Teva, MedinCell  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Uzedy (risperidone XR SC suspension) / Teva, MedinCell
NCT03503318 / 2018-001619-65: Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Checkmark Efficacy and safety data from RISE trial for schizophrenia
Nov 2021 - Nov 2021: Efficacy and safety data from RISE trial for schizophrenia
Completed
3
544
Europe, US
TV-46000, Risperidone, Placebo
Teva Branded Pharmaceutical Products R&D, Inc.
Schizophrenia
09/20
12/20
NCT03893825 / 2019-000063-24: A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Checkmark Safety and efficacy data from RISE study
Jan 2021 - Jan 2021: Safety and efficacy data from RISE study
Checkmark Safety and tolerability data from SHINE study
Jan 2021 - Jan 2021: Safety and tolerability data from SHINE study
Completed
3
336
Europe, Canada, US, RoW
TV-46000, Risperidone, Placebo
Teva Branded Pharmaceutical Products R&D, Inc.
Schizophrenia
12/21
12/21

Download Options